Research Into Visual Endpoints and RB Health Outcomes After Treatment (RIVERBOAT)
Status: Recruiting
Location: See all (11) locations...
Intervention Type: Other, Procedure
Study Type: Observational
SUMMARY
This trial studies health outcomes after treatment in patients with retinoblastoma. Gathering health information over time from patients and family members through vision assessments, samples of tissue and saliva, and questionnaires may help doctors learn more about what causes retinoblastoma, identify long-term health outcomes for patients with retinoblastoma, and find out which therapies may be the best for treating retinoblastoma
Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: t
View:
• Unilateral or bilateral intraocular retinoblastoma
• Diagnosis between the ages of 0 - 17.99 years
• Diagnosis on or after January 1, 2008
Locations
United States
Illinois
Lurie Children's Hospital
RECRUITING
Chicago
University of Illinois, Chicago
RECRUITING
Chicago
Minnesota
University of Minnesoa
RECRUITING
Minneapolis
Missouri
Washington School of Medicine at St. Louis
RECRUITING
St Louis
Ohio
Cincinnati Children's Hospital Medical Center
RECRUITING
Cincinnati
Pennsylvania
Children's Hospital of Philadelphia
RECRUITING
Philadelphia
Tennessee
Vanderbilt-Ingram Cancer Center
RECRUITING
Nashville
Texas
MD Anderson Cancer Center
RECRUITING
Houston
Texas Childeren's Hospital
RECRUITING
Houston
Wisconsin
Children's Hospital of Wisconsin
RECRUITING
Milwaukee
Other Locations
Canada
The Hosptial for Sick Children
RECRUITING
Toronto
Contact Information
Primary
Vanderbilt-Ingram Service for Timely Access
cip@vanderbilt.edu
800-811-8480
Time Frame
Start Date: 2019-01-24
Estimated Completion Date: 2031-01
Participants
Target number of participants: 900
Treatments
Retrospective(biospecimens, vision assessment, questionnaires)
Prospective (biospecimens, vision assessment, questionnaires)
Related Therapeutic Areas
Sponsors
Leads: Vanderbilt-Ingram Cancer Center
Collaborators: National Cancer Institute (NCI)